Your Basket
Your Basket
There are no funds in your basket. To add funds to your basket use the Green Plus Icon wherever you see it next to a fund.
Fund name
Aberdeen American Growth  
Fidelity American  
Schroder UK Mid 250  
M&G Recovery  
Jupiter Merlin UK Growth  
Close Basket Open basket

Login

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table
 
 
 
Poll

Have you been allocating more to cash or equities, given signs of rising risks?

Cash
Equities

Vote

 
You are here: Factsheet
 

FL AXA Framlington Health PSB

FE Crown Rating

Fund Objective

Capital growth through investment in healthcare and medical services and product companies worldwide. Investment will be in producers of pharmaceuticals, biotechnology firms, medical device and instrument manufacturers, distributors of healthcare products, care providers and managers and other healthcare services companies.

Fund Manager

Gemma Game

Fund Manager

Domicile

Sector

Currency

Primary Asset Class

Fund Size

GBX 0.03m as at 24-Oct-2013

Unit Name

FL AXA Framlington Health PSB

Inc/Acc

Accumulating 

Citicode

QQ36

Initial Charge

0.00%

Unit Currency

GBX 

ISIN

GB00B06LCF53 

Annual Charge

1.88%

Mid

GBX 232.80

Change (Mid)

-0.10 (-0.04%)
29-Aug-2014

Unit LaunchDate

12-Jul-2004

Performance Overview

Performance Charts

Cumulative Performance

  YTD 3m 6m 1y 3y 5y
Fund 11.60 6.74 3.88 18.41 76.20 107.52
Sector 3.18 1.99 2.35 6.77 23.19 32.27
 

Discrete Performance (%)

  2013 2012 2011 2010 2009
Fund 29.46 9.60 4.28 15.27 15.41
Sector 10.14 6.76 -5.30 8.11 18.93

Asset Allocation

breakdown chart
  Asset Class % of Fund
US Equities 68.43
Swiss Equities 11.59
UK Equities 6.74
German Equities 2.81
Israeli Equities 2.11
Money Market 1.93
Irish Equities 1.54
Japanese Equities 1.26
French Equities 0.92
Canadian Equities 0.84
Australian Equities 0.79
South African Equities 0.72
Brazilian Equities 0.32

Regional Breakdown

breakdown chart
  Region % of Fund
United States 68.43
Switzerland 11.59
United Kingdom 6.74
Germany 2.81
Israel 2.11
Cash 1.93
Ireland 1.54
Japan 1.26
France 0.92
Canada 0.84
Australia 0.79
South Africa 0.72
Brazil 0.32

Sector Breakdown

breakdown chart
  Sector % of Fund
Specialty Pharma & Pharma 32.20
Healthcare Services & Enabling Technology / Tools 29.80
Devices 19.06
Biotech Product 17.01
Cash 1.93

All prices in Pence Sterling (GBX) unless otherwise specified. Price performance figures are calculated on a bid price to bid price basis with net income (dividends) reinvested. Performance figures are shown in Sterling.

 
 
Sign up for email alerts
Stay upto date on the latest fund research from FE
 
subscribe Readers of this page also looked at:
Readers of this Factsheet have not looked at any others
 
 
 
Add your comment
 
Reload Change mode
 
Enter the words above:
Send comment
 
Be the first to comment on this Factsheet.
 
  • Stay connected with FE trustnet
  • Authorised and Regulated by the
    Financial Conduct Authority
  • © Trustnet Limited . All Rights Reserved.
  • Please read our Terms of Use / Disclaimer
    and Privacy and Cookie Policy.
  • Data supplied in conjunction with Thomson Financial Limited,
    London Stock Exchange Plc, StructuredRetailProducts.com
    and ManorPark.com